Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma informs about press release
Date: 01-10-2021Natco Pharma has informed that it enclosed press release titled ‘Natco Announces Launch of its 10mg strength for Everolimus Tablets (generic for Afinitor) in the US market’.
The above information is a part of company’s filings submitted to BSE.